Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis (Q33615236)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

visceral leishmaniasis

1 reference

based on heuristic

inferred from title

Rajesh Ravindran

1

object named as

Rajesh Ravindran

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Sudipta Bhowmick

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Amrita Das

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Nahid Ali

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

24 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BMC Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

181

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Towards improved understanding of protective mechanisms induced by the BCG vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Identification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

New horizons in adjuvants for vaccine development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

First generation leishmaniasis vaccines: a review of field efficacy trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Leishmaniasis: current situation and new perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Adjuvanticity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904331

21 June 2018

Influence of phospholipid composition on the adjuvanticity and protective efficacy of liposome-encapsulated Leishmania donovani antigens

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Prophylactic efficacy of high-molecular-weight antigenic fractions of a recent clinical isolate of Leishmania donovani against visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Effects of combined BCG and DHEA treatment in preventing the development of asthma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Colorimetric determination of phospholipids with ammonium ferrothiocyanate

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2180-10-181

21 January 2018

The effect of BCG on experimental cutaneous leishmaniasis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic Effect of Bacillus Calmette Guerin and a Tuberculosis Subunit Vaccine in Cationic Liposomes: Increased Immunogenicity and Protection

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toll-like receptor 9 contributes to recognition of Mycobacterium bovis Bacillus Calmette-Guérin by Flt3-ligand generated dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent developments in leishmaniasis vaccine delivery systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of macrophages in the induction and regulation of immunity elicited by exogenous antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576102

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2180-10-181

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33615236&oldid=2195570631"